Atopy and risk of brain tumors: A meta-analysis

Journal of the National Cancer Institute

Volumn 99, Issue 20, 2007, Pages 1544-1550

  Linos, Eleni ^a   Raine, Tim ^b   Alonso, Alvaro ^a   Michaud, Dominique ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGY; ARTICLE; ASTHMA; ATOPY; CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CUSTODY; DATA BASE; ECZEMA; EMBASE; GLIOMA; HAY FEVER; HISTORY; HUMAN; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDLINE; MENINGIOMA; META ANALYSIS; METHODOLOGY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PUBLISHING; RISK; RISK FACTOR; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; HYPERSENSITIVITY; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOLOGY; INCIDENCE; RISK ASSESSMENT;

ASTHMA; CASE-CONTROL STUDIES; COHORT STUDIES; ECZEMA; GLIOMA; HUMANS; HYPERSENSITIVITY; HYPERSENSITIVITY, IMMEDIATE; INCIDENCE; MENINGIOMA; ODDS RATIO; PUBLICATION BIAS; RESEARCH DESIGN; RHINITIS, ALLERGIC, SEASONAL; RISK ASSESSMENT; RISK FACTORS;

EID: 35548956467     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djm170     Document Type: Article

References (37)

1. Hochberg F, Toniolo P, Cole P, Salcman M. Nonoccupational risk indicators of glioblastoma in adults. J Neurooncol 1990;8:55-60.
2. Ryan P, Lee MW, North B, McMichael AJ. Risk factors for tumors of the brain and meninges: results from the Adelaide Adult Brain Tumor Study. Int J Cancer 1992;51:20-7.
3. Schlehofer B, Blettner M, Becker N, Martinsohn C, Wahrendorf J. Medical risk factors and the development of brain tumors. Cancer 1992;69:2541-7.
4. Cicuttini FM, Hurley SF, Forbes A, Donnan GA, Salzberg M, Giles GG, et al. Association of adult glioma with medical conditions, family and reproductive history. Int J Cancer 1997;71:203-7.
5. Schlehofer B, Blettner M, Preston-Martin S, Niehoff D, Wahrendorf J, Arslan A, et al. Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer 1999;82:155-60.
6. Wiemels JL, Wiencke JK, Sison JD, Miike R, McMillan A, Wrensch M. History of allergies among adults with glioma and controls. Int J Cancer 2002;98:609-15.
7. Brenner AV, Linet MS, Fine HA, Shapiro WR, Selker RG, Black PM, et al. History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer 2002;99:252-9.
8. Schwartzbaum J, Jonsson F, Ahlbom A, Preston-Martin S, Lonn S, Soderberg KC, et al. Cohort studies of association between self-reported allergic conditions, immune-related diagnoses and glioma and meningioma risk. Int J Cancer 2003;106:423-8.
9. Schoemaker MJ, Swerdlow AJ, Hepworth SJ, McKinney PA, van Tongeren M, Muir KR. History of allergies and risk of glioma in adults. Int J Cancer 2006;119:2165-72.
10. Schoemaker MJ, Swerdlow AJ, Hepworth SJ, van Tongeren M, Muir KR, McKinney PA. History of allergic disease and risk of meningioma. Am J Epidemiol 2007;165:477-85.
11. Okada H, Villa L, Attanucci J, Erff M, Fellows WK, Lotze MT, et al. Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells. Gene Ther 2001;8:1157-66.
12. Benedetti S, Di Meco F, Cirenei N, Bruzzone MG, Pollo B, Florio N, et al. IL-4 gene transfer for the treatment of experimental gliomas. Adv Exp Med Biol 1998;451:315-21.
13. Schwartzbaum J, Ahlbom A, Malmer B, Lonn S, Brookes AJ, Doss H, et al. Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res 2005;65:6459-65.
14. Wiemels JL, Wiencke JK, Patoka J, Moghadassi M, Chew T, McMillan A, et al. Reduced immunoglobulin E and allergy among adults with glioma compared with controls. Cancer Res 2004;64:8468-73.
15. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
16. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
17. Egger M, Smith GD, Altman DG, editors. Systematic reviews in healthcare: meta-analysis in context. 2nd ed. BMJ; 2001.
18. Rosenberg MS. The file-drawer problem revisited: a general weighted method for calculating fail-safe numbers in meta-analysis. Evolution Int J Org Evolution 2005;59:464-8.
19. Sutton AJ, Song F, Gilbody SM, Abrams KR. Modelling publication bias in meta-analysis: a review. Stat Methods Med Res 2000;9:421-45.
20. StataCorp. Stata Statistical Software: release 9. College Station (TX): StatCorp LP; 2005.
21. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12.
22. Howard TD, Koppelman GH, Xu J, Zheng SL, Postma DS, Meyers DA, et al. Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma. Am J Hum Genet 2002;70:230-6.
23. Heinzmann A, Mao XQ, Akaiwa M, Kreomer RT, Gao PS, Ohshima K, et al. Genetic variants of IL-13 signalling and human asthma and atopy. Hum Mol Genet 2000;9:549-59.
24. Howard TD, Whittaker PA, Zaiman AL, Koppelman GH, Xu J, Hanley MT, et al. Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population. Am J Respir Cell Mol Biol 2001;25:377-84.
25. Barker CF, Billingham RE. Immunologically privileged sites. Adv Immunol 1977;25:1-54.
26. Mahaley MS Jr, Brooks WH, Roszman TL, Bigner DD, Dudka L, Richardson S. Immunobiology of primary intracranial tumors. Part 1: studies of the cellular and humoral general immune competence of brain-tumor patients. J Neurosurg 1977;46:467-76.
27. Palma L, Di Lorenzo N, Guidetti B. Lymphocytic infi ltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, relevance to prognosis in 228 operated cases. J Neurosurg 1978;49:854-61.
28. Nano R, Ceroni M. The immunobiology of malignant gliomas. Funct Neurol 2005;20:39-42.
29. Benedetti S, Pirola B, Pollo B, Magrassi L, Bruzzone MG, Rigamonti D, et al. Gene therapy of experimental brain tumors using neural progenitor cells. Nat Med 2000;6:447-50.
30. Kuppner MC, Hamou MF, Sawamura Y, Bodmer S, de Tribolet N. Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor beta 2. J Neurosurg 1989;71:211-7.
31. Lingnau K, Hoehn P, Kerdine S, Koelsch S, Neudoerfl C, Palm N, et al. IL-4 in combination with TGF-beta favors an alternative pathway of Th1 development independent of IL-12. J Immunol 1998;161:4709-18.
32. Giezeman-Smits KM, Okada H, Brissette-Storkus CS, Villa LA, Attanucci J, Lotze MT, et al. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity. Cancer Res 2000;60:2449-57.
33. Volpert OV, Fong T, Koch AE, Peterson JD, Waltenbaugh C, Tepper RI, et al. Inhibition of angiogenesis by interleukin 4. J Exp Med 1998;188:1039-46.
34. Barna BP, Barnett GH, Jacobs BS, Estes ML. Divergent responses of human astrocytoma and non-neoplastic astrocytes to tumor necrosis factor alpha involve the 55 kDa tumor necrosis factor receptor. J Neuroimmunol 1993;43:185-90.
35. Liu H, Jacobs BS, Liu J, Prayson RA, Estes ML, Barnett GH, et al. Interleukin-13 sensitivity and receptor phenotypes of human glial cell lines: non-neoplastic glia and low-grade astrocytoma differ from malignant glioma. Cancer Immunol Immunother 2000;49:319-24.
36. Toren K, Brisman J, Jarvholm B. Asthma and asthma-like symptoms in adults assessed by questionnaires. A literature review. Chest 1993;104:600-8.
37. Walker PR, Calzascia T, Dietrich PY. All in the head: obstacles for immune rejection of brain tumours. Immunology 2002;107:28-38